Search - tctmd.com

Displaying 21 - 40 of 116

Sort: Relevancy | Date

News Conference News TCT 2022

Newer FlexNav Delivery System Improves Placement of Portico TAVI Valve

Todd Neale

September 19, 2022

Presentation TCT 2022

TCT 370: Negative Compared to Positive Echocardiographic Imaging of Infective Endocarditis After Transcatheter Aortic Valve Implantation

Presenter: Norman Mangner

September 19, 2022

Presentation TCT 2022

TCT 605: Single Arterial Access for Transfemoral Transcatheter Aortic Valve Implantation with the Acurate neo Self-expanding Aortic Bioprosthesis

Presenter: Rodrigo Bagur

September 19, 2022

Presentation TCT 2022

TCT 368: Core Lab Quantitative Angiographic Assessment of Residual Aortic Regurgitation after Implantation of Portico Transcatheter Aortic Valve

Presenter: Ahmed Elkoumy

September 19, 2022

Presentation TCT 2022

TCT 332: Clinical outcome of transcatheter aortic valve replacement with TriGUARD 3™ cerebral embolic protection device

Presenter: Sayonara Daal

September 19, 2022

Presentation TCT 2022

TCT 367: Is Discordance Between Echocardiography and Invasive Trans Aortic Valve Mean Gradients Related to Pressure Recovery?

Presenter: Luai Madanat

September 19, 2022

Presentation TCT 2022

TCT 602: Comparison of Bleeding and Vascular Complications With Single Versus Double Proglide Vascular Closure After Transcatheter Aortic Valve Replacement

Presenter: Alan Zajarias

September 19, 2022

Presentation TCT 2022

TCT 366: Comparison of Hemodynamic Performance of Transcatheter Aortic Valve Replacement with Supra-Annular Self-Expanding versus Balloon-Expandable Valves Assessed by Exercise Cardiovascular Magnetic Resonance

Presenter: Luis Augusto Palma Dallan

September 19, 2022

Presentation TCT 2022

TCT 606: Transcarotid Versus Transaxillary Access for Transcatheter Aortic Valve Replacement With a Self-Expanding, Supra-Annular Valve

Presenter: Keith Allen

September 19, 2022

Presentation TCT 2022

Cardiac Damage and Quality of Life After Aortic Valve Replacement: Results From the PARTNER Trials

Presenter: Philippe Genereux

September 18, 2022

Presentation TCT 2022

Increased Risk of Surgical Aortic Valve Replacement After Prior Transcatheter vs Surgical Aortic Valve Replacement

Presenter: Robert Hawkins

September 18, 2022

Presentation TCT 2022

Frequency and Safety of Bioprosthetic Valve Fracture in Patients Undergoing Valve in Valve TAVR for Failed Surgical Valves Using the SAPIEN 3/Ultra Valves: Insights From Real-World Data

Presenter: Santiago Garcia

September 18, 2022

Presentation TCT 2022

Mediators of Improvement in TAVR Outcomes Over Time: Insights From the STS-ACC TVT Registry

Presenter: Suzanne Arnold

September 18, 2022

Presentation TCT 2022

TCT 329: Cerebral Embolic Protection Devices For Prevention Of Post-Procedural Ischemic Stroke With Transcatheter Aortic Valve Replacement: A SYSTEMATIC REVIEW AND META-ANALYSIS

Presenter: Tanesh Ayyalu

September 18, 2022

Presentation TCT 2022

TCT 328: Low-dose or Standard-dose Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombus and Cerebral Thromboembolism after Transcatheter Aortic Valve Replacement (TAVR): Subgroup Analysis of the Randomized ADAPT-TAVR Trial

Presenter: Mijin Kim

September 18, 2022

Presentation TCT 2022

Case Resolution

Presenter: Tom Cahill

September 18, 2022

Presentation TCT 2022

How Will Emerging Evidence Help Us?

Presenter: Philippe Genereux

September 18, 2022

Presentation TCT 2022

What Do the Guidelines Say?

Presenter: Victoria Delgado

September 18, 2022

Presentation TCT 2022

Case Presentation: A 70 Year-old Low-risk Woman With Asymptomatic Severe Aortic Stenosis

Presenter: Tom Cahill

September 18, 2022

Presentation TCT 2022

Three-Year Outcomes of the Randomized SCOPE I Trial Comparing the ACURATE Neo vs the SAPIEN 3 Transcatheter Heart Valve System in Patients With Symptomatic Severe Aortic Stenosis

Presenter: Jonas Lanz

September 17, 2022

Advertisement

Newer FlexNav Delivery System Improves Placement of Portico TAVI Valve

TCT 370: Negative Compared to Positive Echocardiographic Imaging of Infective Endocarditis After Transcatheter Aortic Valve Implantation

TCT 605: Single Arterial Access for Transfemoral Transcatheter Aortic Valve Implantation with the Acurate neo Self-expanding Aortic Bioprosthesis

TCT 368: Core Lab Quantitative Angiographic Assessment of Residual Aortic Regurgitation after Implantation of Portico Transcatheter Aortic Valve

TCT 332: Clinical outcome of transcatheter aortic valve replacement with TriGUARD 3™ cerebral embolic protection device

TCT 367: Is Discordance Between Echocardiography and Invasive Trans Aortic Valve Mean Gradients Related to Pressure Recovery?

TCT 602: Comparison of Bleeding and Vascular Complications With Single Versus Double Proglide Vascular Closure After Transcatheter Aortic Valve Replacement

TCT 366: Comparison of Hemodynamic Performance of Transcatheter Aortic Valve Replacement with Supra-Annular Self-Expanding versus Balloon-Expandable Valves Assessed by Exercise Cardiovascular Magnetic Resonance

TCT 606: Transcarotid Versus Transaxillary Access for Transcatheter Aortic Valve Replacement With a Self-Expanding, Supra-Annular Valve

Cardiac Damage and Quality of Life After Aortic Valve Replacement: Results From the PARTNER Trials

Increased Risk of Surgical Aortic Valve Replacement After Prior Transcatheter vs Surgical Aortic Valve Replacement

Frequency and Safety of Bioprosthetic Valve Fracture in Patients Undergoing Valve in Valve TAVR for Failed Surgical Valves Using the SAPIEN 3/Ultra Valves: Insights From Real-World Data

Mediators of Improvement in TAVR Outcomes Over Time: Insights From the STS-ACC TVT Registry

TCT 329: Cerebral Embolic Protection Devices For Prevention Of Post-Procedural Ischemic Stroke With Transcatheter Aortic Valve Replacement: A SYSTEMATIC REVIEW AND META-ANALYSIS

TCT 328: Low-dose or Standard-dose Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombus and Cerebral Thromboembolism after Transcatheter Aortic Valve Replacement (TAVR): Subgroup Analysis of the Randomized ADAPT-TAVR Trial

Case Resolution

How Will Emerging Evidence Help Us?

What Do the Guidelines Say?

Case Presentation: A 70 Year-old Low-risk Woman With Asymptomatic Severe Aortic Stenosis

Three-Year Outcomes of the Randomized SCOPE I Trial Comparing the ACURATE Neo vs the SAPIEN 3 Transcatheter Heart Valve System in Patients With Symptomatic Severe Aortic Stenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content